INCENP

Inner centromere protein · Q9NQS7 · INCENP on Sugi Atlas →

14,517 patent compounds predicted against INCENP, 8,649 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Hydrochloric Acid Hydrochloric Acid (SCHEMBL1500997) 1.00 17/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL1501000) 1.00 17/20
Trifluoroacetic Acid Trifluoroacetic Acid (SCHEMBL1501006) 0.77 17/20
Trifluoroacetic Acid Trifluoroacetic Acid (SCHEMBL1056832) 0.64 17/20
SCHEMBL1501008 SCHEMBL1501008 0.62 17/20
SCHEMBL1500998 SCHEMBL1500998 0.53 17/20
SCHEMBL1501004 SCHEMBL1501004 0.53 17/20
SCHEMBL1500971 SCHEMBL1500971 0.72 16/20
SCHEMBL1500972 SCHEMBL1500972 0.72 16/20
Trifluoroacetic Acid Trifluoroacetic Acid (SCHEMBL1055761) 0.53 16/20
SCHEMBL1500854 SCHEMBL1500854 0.72 15/20
SCHEMBL1500855 SCHEMBL1500855 0.72 15/20
SCHEMBL1500858 SCHEMBL1500858 0.72 15/20
SCHEMBL527521 SCHEMBL527521 0.55 13/20
SCHEMBL527522 SCHEMBL527522 0.55 13/20
Trifluoroacetic Acid Trifluoroacetic Acid (SCHEMBL1055755) 0.55 13/20
SCHEMBL527633 SCHEMBL527633 0.53 13/20
SCHEMBL527634 SCHEMBL527634 0.53 13/20
SCHEMBL1055757 SCHEMBL1055757 0.52 13/20
Inamrinone Inamrinone (SCHEMBL44012) 1.00 12/20

Clinical trials — most relevant to INCENP by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Phase I Study to Assess the Safety, Pharmacokinetics, & Pharmacodynamics of GSK923295 in Subjects w/ Refractory Cancer PHASE1COMPLETED
Breakpoint Analysis of de Novo Apparently Balanced Chromosomal Translocations EARLY_PHASE1COMPLETED
PCM1-JAK2 in Therapy Related Neoplasms nanUNKNOWN
Tobacco and Sperm Genome: Effects of Smoking Cessation nanCOMPLETED
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF) nanUNKNOWN
Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins nanCOMPLETED
PCD New Gene Discovery nanCOMPLETED
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease nanRECRUITING
Chromosome 9 P Minus Syndrome nanRECRUITING
Genetics of Primary Ciliary Dyskinesia nanCOMPLETED
Validation of Optical Genome Mapping for the Identification of Constitutional Genomic Variants in a Postnatal Cohort nanUNKNOWN
Cytogenetic Study of Ocular Melanoma nanCOMPLETED
A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia for Potential Clinical Trials nanACTIVE_NOT_RECRUITING
Genetic Study of Patients With Primary Ciliary Dyskinesia nanCOMPLETED
Diagnosis of Primary Ciliary Dyskinesia nanCOMPLETED
The Contribution of Optical Mapping to the Characterization of Chromosomal Rearrangements in Patients With Neurodevelopmental Disorders nanRECRUITING
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
Inter-regional Project of the Great Western Exploration Approach for Exome Molecular Causes Severe Intellectual Disability Isolated or Syndromic nanCOMPLETED
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others nanRECRUITING
Characterizing the Upper Airway Manifestations in Primary Ciliary Dyskinesia and Primary Immunodeficiencies nanCOMPLETED
Whole Genome Scan of Extended Families With Familial Vocal Cord Paralysis nanCOMPLETED
Molecular Profiling to Improve Outcome of Patients in Cancer. A Pilot Study nanCOMPLETED
Prenatal Cell-free DNA Screening in Pregnancies With Diverse Genetic Risk Profiles Utilizing Targeted and Whole-exome Sequencing nanNOT_YET_RECRUITING
Genetic Investigation of Solid Tumors Cohort nanCOMPLETED
Association of Previously Verified Gene Polymorphisms With AMD in Turkish Population nanUNKNOWN
Biological Aging Hallmarks-Guided Integrative TCM and Conventional Medicine in Post-Treatment Unexplained Female Infertility nanRECRUITING
Microarray Analysis in Syndromic Obesity nanCOMPLETED
IPSC Repository of Pediatric Cardiovascular Disease nanRECRUITING
Telomeres Length in Israeli Fibrotic ILD Patients nanENROLLING_BY_INVITATION
Development of a Newborn Screening Assay for Angelman Syndrome and Prader-Willi Syndrome nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a INCENP binder may also engage these)

ProteinNameSimilarity
Q9WU62 1.000 Q9WU62 →
P53352 0.999 P53352 →
A6QLA6 0.996 A6QLA6 →
Q96T17 0.995 Q96T17 →
Q6PCQ0 0.994 Q6PCQ0 →
MAP7 Ensconsin 0.994 landscape →
D4A4L4 0.994 D4A4L4 →
Q5ZIA2 0.993 Q5ZIA2 →
A0JMK9 0.993 A0JMK9 →
Q32N93 0.992 Q32N93 →
Q922B9 0.992 Q922B9 →
A2AHC3 0.992 A2AHC3 →
O88735 0.991 O88735 →
Q9Y6A5 0.991 Q9Y6A5 →
Q58CQ0 0.991 Q58CQ0 →
O18805 0.991 O18805 →
O13024 0.990 O13024 →
P46529 0.990 P46529 →
Q8CCG4 0.990 Q8CCG4 →
E9QG33 0.990 E9QG33 →
E7F5E1 0.990 E7F5E1 →
Q8VDP4 0.989 Q8VDP4 →
Q9Y6F6 0.989 Q9Y6F6 →
A1X157 0.989 A1X157 →
Q9WUX5 0.989 Q9WUX5 →
Q6IPM2 0.989 Q6IPM2 →
Q5R7F9 0.989 Q5R7F9 →
Q0IHP2 0.989 Q0IHP2 →
Q9JHU2 0.989 Q9JHU2 →
Q5RG44 0.989 Q5RG44 →